Highbush blueberry proanthocyanidins alleviate Porphyromonas gingivalis-induced deleterious effects on oral mucosal cells.
Bacteroidaceae Infections
/ drug therapy
Blueberry Plants
/ chemistry
Cells, Cultured
Cytokines
/ biosynthesis
Humans
Inflammation Mediators
/ metabolism
Keratinocytes
/ drug effects
Mouth Mucosa
/ microbiology
Periodontitis
/ drug therapy
Porphyromonas gingivalis
/ drug effects
Proanthocyanidins
/ pharmacology
Journal
Anaerobe
ISSN: 1095-8274
Titre abrégé: Anaerobe
Pays: England
ID NLM: 9505216
Informations de publication
Date de publication:
Oct 2020
Oct 2020
Historique:
received:
20
04
2020
revised:
18
08
2020
accepted:
28
08
2020
pubmed:
2
9
2020
medline:
23
6
2021
entrez:
2
9
2020
Statut:
ppublish
Résumé
Strong evidence points to Porphyromonas gingivalis, a Gram-negative anaerobic bacterium, as a keystone species in the development of the chronic form of periodontitis. The aim of the present study was to investigate the ability of highbush blueberry proanthocyanidins (PACs) to alleviate the P. gingivalis-induced deleterious effects on oral mucosal cells. We first showed that highbush blueberry PACs protect the integrity of the gingival keratinocyte barrier against P. gingivalis-mediated damage, as determined by measuring the transepithelial electrical resistance and paracellular flux of FITC-conjugated dextran. Moreover, the PACs prevented the translocation of P. gingivalis across the gingival keratinocyte barrier model. The proteinase activity of P. gingivalis was inhibited by the PACs suggesting that they may exert beneficial effects by reducing proteolytic degradation of the epithelial tight junctions. Regulation of gingival fibroblast inflammatory reactions may be one of the ways to prevent and control periodontal disease progression and severity. We showed that PACs significantly reduce IL-6 and IL-8 secretion by P. gingivalis-stimulated gingival fibroblasts. The present study showed the capacity of highbush blueberry PACs to protect the integrity of an in vitro model of gingival keratinocyte barrier against P. gingivalis, and to attenuate the secretion of pro-inflammatory cytokines by gingival fibroblasts infected with P. gingivalis. These results suggest beneficial effects of blueberry PACs thus supporting the need for future clinical trials on the potential of these bioactive molecules for periodontal disease prevention and/or treatment.
Identifiants
pubmed: 32871243
pii: S1075-9964(20)30122-0
doi: 10.1016/j.anaerobe.2020.102266
pii:
doi:
Substances chimiques
Cytokines
0
Inflammation Mediators
0
Proanthocyanidins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
102266Informations de copyright
Copyright © 2020 Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.